10-Q
Quarterly Report
SONOMA PHARMACEUTICALS, INC.
SNOA
NASDAQ
CIK: 1367083
File #: 001-33216
Balance Sheet
37 line items · 2 periods
XBRL
| Item | Dec 31, 2024 | Mar 31, 2024 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 5,236,000 | 3,128,000 |
Accounts Receivable | 2,405,000 | 2,898,000 |
Inventory | 3,143,000 | 2,719,000 |
Other Non-Operating Current Assets | 1,387,000 | 3,541,000 |
Current portion of deferred consideration, net of discount | 209,000 | 262,000 |
Total current assets | 12,380,000 | 12,548,000 |
Property, Plant and Equipment | 215,000 | 365,000 |
Operating Lease Right-of-Use Asset | 119,000 | 286,000 |
Deferred Tax Assets, Non-Current | 760,000 | 1,145,000 |
Deferred consideration, net of discount, less current portion | 121,000 | 330,000 |
Other Non-Operating Non-Current Assets | 73,000 | 66,000 |
Total assets | 13,668,000 | 14,740,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 1,395,000 | 607,000 |
Accounts Payable | 1,916,000 | 2,113,000 |
Other Current Liabilities | 302,000 | 478,000 |
Short-Term Debt | 0 | 323,000 |
Operating Lease Liability, Current | 90,000 | 198,000 |
Total current liabilities | 3,703,000 | 3,719,000 |
Warranty and Other Provisions | 30,000 | 87,000 |
Withholding tax payable | 5,036,000 | 4,710,000 |
Operating Lease Liability, Non-Current | 29,000 | 87,000 |
Total liabilities | 8,798,000 | 8,603,000 |
Stockholders’ Equity: | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 0 | 0 |
Total Stockholders' Equity | 206,454,000 | 203,209,000 |
Total Stockholders' Equity | (197,030,000) | (194,349,000) |
Total Stockholders' Equity | (4,554,000) | (2,723,000) |
Total stockholders’ equity | 4,870,000 | 6,137,000 |
Additional Paid-in Capital | 206,454,000 | 203,209,000 |
Retained Earnings | (197,030,000) | (194,349,000) |
AOCI Attributable to Parent | (4,554,000) | (2,723,000) |
Total liabilities and stockholders’ equity | 13,668,000 | 14,740,000 |